Skip to main content
. Author manuscript; available in PMC: 2019 Dec 10.
Published in final edited form as: Nat Rev Drug Discov. 2017 Dec 8;17(4):280–299. doi: 10.1038/nrd.2017.221

Figure 2 |. Clinical trials performed since 2002 in fragile X syndrome.

Figure 2 |

Trial duration and primary outcome measures are displayed for each trial. On the far right, the size of the circles is proportional to the number of participants enrolled in the study. mGluR5, metabotropic glutamate receptor 5. Adapted with permission from Nicolas Rapp, Spectrum (https://spectrumnews.org/news/despite-setbacks-fragile-x-drugs-file-clinical-trials/).